ChemPartner PharmaTech Co.,Ltd. (SHE:300149)
China
· Delayed Price · Currency is CNY 10.15
-0.33 (-3.15%)
Last updated: Jun 5, 2025
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2016 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2016 - 2018 |
| Pharmaceutical Research and Development and Production Outsourcing | 1.13B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Pharmaceutical Research and Development and Production Outsourcing Growth | -4.92% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Headquarters and Industrial Funds | 3.84M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Headquarters and Industrial Funds Growth | -9.80% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Microecological Nutrition and Medical | 3.65M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Microecological Nutrition and Medical Growth | -97.33% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Adjustment and Eliminations | -1.82M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Adjustment and Eliminations Growth | -70.24% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2016 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2016 - 2018 |
| United States | 813.00M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| United States Growth | 3.55% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| China | 196.65M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| China Growth | -49.83% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Countries or Regions | 128.72M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Countries or Regions Growth | -13.87% |
Log In |
Log In |
Log In |
Log In | Upgrade
|